The global chromosome enumeration probes (CEP) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The continuous growing prevalence of target disorders, the rising investments in in-vitro diagnostics space, coupled with the technological advancements in in-situ hybridization (ISH) are a few of the pivotal factors driving the market growth. Another key factor driving the market growth includes the key role of CEPs in many applications, including them to be used to determine chromosome copy numbers in the diagnosis and prognosis of cancer and other diseases. Adding to this, the rising number of cancer and autoimmune diseases further demand their diagnosis using advanced solutions such as CEP. All these factors are anticipated to add to the growth of the market. Further, the rising adoption of Digital Droplet PCR (ddPCR) and Multiplex Ligation-dependent Probe Amplification (MLPA) in the biotechnology field for detection and thus the treatment of various complex diseases is projected to provide a boost to the market growth.

The growing research related to the genome coupled with the advancements in the biotechnology vertical has paved numerous opportunities for market growth. Some other major factors which primarily include the rising prevalence of blood disorders along with the rising awareness about such disorders and the presence of sophisticated & advanced technologies are anticipated to propel the market. The COVID-19 pandemic also served as a driving factor for the market growth. In June 2021, The University of Oxford collaborated with the University of Warwick to research a method to detect the COVID-19 virus in 20 minutes using in-situ hybridization. This technology is previously used to detect pathogens inside cells, such as the Epstein-Barr and HIV. Such developments are expected to propel market growth during the forecast period. Furthermore, some key players operating in the market include Abbott Laboratories, BioCat GmbH, and Empire Genomics, Inc., among others.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Abbott Laboratories, BioCat GmbH, and Empire Genomics, Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Chromosome Enumeration Probes (CEP) Market by Segment

By Product 

• Single Color Probes

• Dual Color Probes

• Multi-color Probes

By Application 

• Cancer

• Autoimmune Diseases

Global Chromosome Enumeration Probes (CEP) Market by Region